Correlation Between Lifecore Biomedical and Orexo AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lifecore Biomedical and Orexo AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lifecore Biomedical and Orexo AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lifecore Biomedical and Orexo AB ADR, you can compare the effects of market volatilities on Lifecore Biomedical and Orexo AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lifecore Biomedical with a short position of Orexo AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lifecore Biomedical and Orexo AB.

Diversification Opportunities for Lifecore Biomedical and Orexo AB

-0.86
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Lifecore and Orexo is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Lifecore Biomedical and Orexo AB ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orexo AB ADR and Lifecore Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lifecore Biomedical are associated (or correlated) with Orexo AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orexo AB ADR has no effect on the direction of Lifecore Biomedical i.e., Lifecore Biomedical and Orexo AB go up and down completely randomly.

Pair Corralation between Lifecore Biomedical and Orexo AB

Given the investment horizon of 90 days Lifecore Biomedical is expected to generate 0.88 times more return on investment than Orexo AB. However, Lifecore Biomedical is 1.14 times less risky than Orexo AB. It trades about 0.27 of its potential returns per unit of risk. Orexo AB ADR is currently generating about 0.09 per unit of risk. If you would invest  593.00  in Lifecore Biomedical on August 31, 2024 and sell it today you would earn a total of  157.00  from holding Lifecore Biomedical or generate 26.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Lifecore Biomedical  vs.  Orexo AB ADR

 Performance 
       Timeline  
Lifecore Biomedical 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Lifecore Biomedical are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady fundamental indicators, Lifecore Biomedical reported solid returns over the last few months and may actually be approaching a breakup point.
Orexo AB ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Orexo AB ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Lifecore Biomedical and Orexo AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lifecore Biomedical and Orexo AB

The main advantage of trading using opposite Lifecore Biomedical and Orexo AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lifecore Biomedical position performs unexpectedly, Orexo AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orexo AB will offset losses from the drop in Orexo AB's long position.
The idea behind Lifecore Biomedical and Orexo AB ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format